Announce Date | 05/07/2025 |
EPS Normalized Actual | $1.06 (Beat by $0.23) |
EPS GAAP Actual | $1.06 (Beat by $0.23) |
Revenue Actual | $2.636B |
Revenue Surprise | Beat by $2636M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $1.26247 |
EPS GAAP Estimate | $1.26247 |
Revenue Estimate | $2.365364477B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 4.81 | 4.06 | 3.99742 | 5.77492 | 1 |
Dec 2028 | 5.31 | 3.68 | 4.9237 | 5.64494 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.96 | 0.96 | 2.636B | 27.81% | 2636M |
FQ4 2024 (Dec 2024) | 0.96 | 0.96 | 2.712B | 20.1% | 2712M |
FQ3 2024 (Sep 2024) | -1.62 | -1.62 | 2.531B | 8.81% | 2531M |
FQ2 2024 (Jun 2024) | 1.46 | 1.46 | 2.543B | 29.37% | 2543M |
FQ1 2024 (Mar 2024) | 0.44 | 0.44 | 1.903B | -5.52% | 1903M |
FQ4 2023 (Dec 2023) | 5.48 | 5.48 | 2.167B | -14.07% | 2167M |
FQ3 2023 (Sep 2023) | 1.49 | 1.49 | 2.308B | -25.09% | 2308M |
FQ2 2023 (Jun 2023) | 1.24 | 1.24 | 1.796B | -69.65% | 1796M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
1.26247
Consensus Revenue Estimates
2.365364477B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 1.1863 | -- | 1.04287 | 1.34289 | 5 |
FQ3 2027 (Sep 2027) | 1.1727 | -- | 1.03092 | 1.3275 | 5 |
FQ2 2027 (Jun 2027) | 1.1244 | -- | 0.98846 | 1.27282 | 5 |
FQ1 2027 (Mar 2027) | 1.118 | -- | 0.98283 | 1.26558 | 5 |
FQ4 2026 (Oct 2026) | 1.30838 | -- | 1.19153 | 1.41345 | 9 |
FQ3 2026 (Jul 2026) | 1.26812 | -- | 1.15487 | 1.36996 | 9 |
FQ2 2026 (Jun 2026) | 1.22905 | -- | 1.06587 | 1.37275 | 9 |
FQ1 2026 (Mar 2026) | 1.23945 | 22.55 | 1.07489 | 1.38436 | 9 |
FQ4 2025 (Oct 2025) | 1.30198 | 26.27 | 1.18571 | 1.40654 | 7 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 4.09B | -- | 3.71B | 4.51B | 6 |
FQ3 2027 (Sep 2027) | 3.94B | -- | 3.58B | 4.34B | 3 |
FQ2 2027 (Jun 2027) | 3.8B | -- | 3.45B | 4.19B | 3 |
FQ1 2027 (Mar 2027) | 3.66B | -- | 3.32B | 4.03B | 3 |
FQ4 2026 (Oct 2026) | 2.4B | -- | 2.24B | 2.55B | 4 |
FQ3 2026 (Jul 2026) | 2.38B | -- | 2.22B | 2.53B | 6 |
FQ2 2026 (Jun 2026) | 2.34B | -- | 2.11B | 2.56B | 5 |
FQ1 2026 (Mar 2026) | 2.33B | -13.2 | 2.09B | 2.54B | 6 |
FQ4 2025 (Oct 2025) | 2.4B | -12.93 | 2.24B | 2.55B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.96 | 0.96 | 100% | |
FQ4 2024 (Dec 2024) | 0.96 | 0.96 | 100% | |
FQ3 2024 (Sep 2024) | -1.62 | -1.62 | 100% | |
FQ2 2024 (Jun 2024) | 1.46 | 1.46 | 100% | |
FQ1 2024 (Mar 2024) | 0.44 | 0.44 | 100% | |
FQ4 2023 (Dec 2023) | 5.48 | 5.48 | 100% | |
FQ3 2023 (Sep 2023) | 1.49 | 1.49 | 100% | |
FQ2 2023 (Jun 2023) | 1.24 | 1.24 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $2.64B | $2636M | 100% |
FQ4 2024 (Dec 2024) | $0B | $2.71B | $2712M | 100% |
FQ3 2024 (Sep 2024) | $0B | $2.53B | $2531M | 100% |
FQ2 2024 (Jun 2024) | $0B | $2.54B | $2543M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.9B | $1903M | 100% |
FQ4 2023 (Dec 2023) | $0B | $2.17B | $2167M | 100% |
FQ3 2023 (Sep 2023) | $0B | $2.31B | $2308M | 100% |
FQ2 2023 (Jun 2023) | $0B | $1.8B | $1796M | 100% |